This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy.

We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.

About NAYO
Download
Contact
About NAYO

Empowering efficiency through innovation.

NAYO (founded in 2015) is a leading Chinese manufacturer and solution provider of laboratory automation. Headquartered in Shanghai with a dedicated R&D center, the company operates a 10,000-square-meter intelligent manufacturing base in Suzhou. With regional offices in Beijing, Chengdu, and Guangzhou, NAYO has established a comprehensive network integrating R&D, production, marketing, and service support. As a specialized OEM partner, we focus on the advanced development of automated instruments and core components, empowering clients through highly customized solutions and engineering excellence. We are committed to transforming laboratory pre-analytical workflows across life sciences, clinical diagnostics, and multi-disciplinary research, focusing on quality, efficiency, and safety.

Our core competitiveness is rooted in the Flexible Architecture of NAYO (FAN). This platform seamlessly integrates precision liquid handling, intelligent motion control, and in-house developed software algorithms, enabling full-stack digital monitoring from underlying architecture to end-user applications. Leveraging the FAN ecosystem, we not only enhance product usability and reliability but also ensure that our systems can rapidly iterate and flexibly scale to meet evolving research demands.

Our product portfolio spans five key dimensions: liquid handling platforms, integrated systems, functional modules, specialized application solutions, and consumables. Our solutions have expanded beyond traditional clinical diagnostics into cutting-edge fields, including synthetic biology, modern agriculture, and forensic science. To date, NAYO has served over 6,000 clients, including industry leaders such as WuXi AppTec, Innovent Biologics, MGI, and KingMed Diagnostics, as well as government agencies like Customs and the CDC, covering 31 provinces across China.

To accelerate our global strategy, NAYO has established a service center in the United States to provide rapid-response technical support. Our products are currently exported to over 10 countries and regions, including the U.S., Europe, and Singapore.


  • 6000+
    Clients served globally
  • 10+
    Sales Network globally
  • 31
    Provinces Served in China
  • 50+
    IPs (applied)
Milestones
2015

NAYO founded in Shanghai with a focus on high-throughput liquid handling; initiated R&D for the N96 desktop workstation, setting the stage for future innovation.


2015

NAYO founded in Shanghai with a focus on high-throughput liquid handling; initiated R&D for the N96 desktop workstation, setting the stage for future innovation.


2016

• Pioneered the graphical UI and labware library to streamline user operation.

2016

• Pioneered the graphical UI and labware library to streamline user operation.

2017

• Launched the A8 platform based on a proprietary "5-in-1" electrical and software architecture;

• Achieved high-density integration of electrical components within an A4-sized footprint;

•Established a benchmark for service excellence with a committed 10-minute technical support response.

2017

• Launched the A8 platform based on a proprietary "5-in-1" electrical and software architecture;

• Achieved high-density integration of electrical components within an A4-sized footprint;

•Established a benchmark for service excellence with a committed 10-minute technical support response.

2018

• Established the Jiaxing manufacturing facility and achieved ISO 9001 certification, ensuring consistent quality for large-scale production.

2018

• Established the Jiaxing manufacturing facility and achieved ISO 9001 certification, ensuring consistent quality for large-scale production.

2019

• Pioneered the ES96 Automated Decapping System, filling a market gap in high-throughput pre-processing and diversifying the product portfolio.

2019

• Pioneered the ES96 Automated Decapping System, filling a market gap in high-throughput pre-processing and diversifying the product portfolio.

2020

 Achieved rapid market expansion with N96 and ES96; 

• Obtained ISO 13485 certification and Medical Device Production License, expanding into the clinical diagnostic sector.


2020

 Achieved rapid market expansion with N96 and ES96; 

• Obtained ISO 13485 certification and Medical Device Production License, expanding into the clinical diagnostic sector.


2021

• Initiated development of the FAN platform; patented "Flexible Sealing" technology, extending tip-fitting life to 300,000 cycles while N96 market share reached 45%.

2021

• Initiated development of the FAN platform; patented "Flexible Sealing" technology, extending tip-fitting life to 300,000 cycles while N96 market share reached 45%.

2022

• Secured a 70% market share for N96, setting the industry benchmark; 

• Released N96 S on the FAN platform and validated advanced thermal control modules.

2022

• Secured a 70% market share for N96, setting the industry benchmark; 

• Released N96 S on the FAN platform and validated advanced thermal control modules.

2023

• Initiated global expansion with the first international delivery of the FAN; 

• Achieved 21 CFR Part 11 compliance to serve the premium global biopharma market.

2023

• Initiated global expansion with the first international delivery of the FAN; 

• Achieved 21 CFR Part 11 compliance to serve the premium global biopharma market.

2024

• Commissioned the 10,000㎡ Suzhou facility; released dual-arm A96 and A8 mini; 

• Expanded into the US market by establishing a North American distribution network.

2024

• Commissioned the 10,000㎡ Suzhou facility; released dual-arm A96 and A8 mini; 

• Expanded into the US market by establishing a North American distribution network.

2025

• Enabled full-platform OTA capabilities;

• Launched specialized solutions for blood aliquoting, NGS library prep, and desktop-level Sample Pooling.


2025

• Enabled full-platform OTA capabilities;

• Launched specialized solutions for blood aliquoting, NGS library prep, and desktop-level Sample Pooling.


2026

• Launched flexible cascading automation systems for diverse scales; 

 Exceeded 50+ premium global clients, driving large-scale international business growth.

2026

• Launched flexible cascading automation systems for diverse scales; 

 Exceeded 50+ premium global clients, driving large-scale international business growth.

×